Paul Phull joins PharmaVentures

pharmafile | August 31, 2010 | Appointment | Sales and Marketing |  PharmaVentures, appointment, sales and marketing 

Oxford, UK-based PharmaVentures has appointed Paul Phull as a senior director to its corporate advisory business.

He joins the company from UK specialty pharma company Sinclair Pharma, where he was responsible for the development of the international business with a marketing partner network spanning over 80 countries.

He has more than 24 years of senior level experience in the pharmaceutical, biotechnology and medical device industries, and in his new role will be responsible for developing PharmaVentures’ corporate advisory business.

Advertisement

“I am very pleased to welcome Paul to PharmaVentures,” said chief executive Dr Fintan Walton. “His strategic approach and industry experience will significantly enhance corporate advisory services, particularly with respect to our transactions offerings.”

Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics

This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

white_and_ford

Abbott CEO to step down after 21 years

After more than two decades at the head of the company, it has emerged that …

The Gateway to Local Adoption Series

Latest content